当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析

苑东生物

(688513)

  

流通市值:59.67亿  总市值:59.67亿
流通股本:1.77亿   总股本:1.77亿

苑东生物(688513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.17亿元,每股收益1.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益267700.94万元,未分配利润112695.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产341821.34万元,负债74120.40万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,039,937,156.56669,513,693.52314,990,089.281,117,120,749.58
营业总成本858,787,446.13543,480,539.83258,240,843.28951,862,398.84
营业利润231,552,226.33159,590,841.8380,220,974.65241,736,982
利润总额231,369,210.18159,456,356.4580,091,272.61241,639,656.18
净利润217,023,597.92146,492,352.8775,010,084.96226,574,420.57
其他综合收益----
综合收益总额217,023,597.92146,492,352.8775,010,084.96226,574,420.57
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,940,299,395.132,039,770,875.931,903,687,347.181,882,871,229.64
非流动资产合计1,477,914,048.21,474,368,523.571,470,683,597.651,463,883,064.24
资产总计3,418,213,443.333,514,139,399.53,374,370,944.833,346,754,293.88
流动负债合计662,572,402.33767,528,649.56666,671,871.78661,094,015.47
非流动负债合计78,631,622.6479,537,197.5881,589,065.7282,240,114.68
负债合计741,204,024.97847,065,847.14748,260,937.5743,334,130.15
归属于母公司股东权益合计2,677,009,418.362,667,073,552.362,626,110,007.332,603,420,163.73
股东权益合计2,677,009,418.362,667,073,552.362,626,110,007.332,603,420,163.73
负债和股东权益合计3,418,213,443.333,514,139,399.53,374,370,944.833,346,754,293.88
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,027,032,791.52660,388,456335,693,559.091,282,171,297.36
经营活动现金流出小计880,386,021.49574,411,813.22263,801,478.591,006,919,058.13
经营活动产生的现金流量净额146,646,770.0385,976,642.7871,892,080.5275,252,239.23
投资活动现金流入小计1,275,405,844.97914,302,659.54631,650,059.043,017,550,300.19
投资活动现金流出小计1,431,639,509.221,082,098,825.42590,353,457.923,427,724,853
投资活动产生的现金流量净额-156,233,664.25-167,796,165.8841,296,601.12-410,174,552.81
筹资活动现金流入小计192,448,787.94183,772,716.8650,000,000244,817,137.59
筹资活动现金流出小计367,920,827.66206,833,323.75113,998,569.1164,146,093.06
筹资活动产生的现金流量净额-175,472,039.72-23,060,606.89-63,998,569.180,671,044.53
汇率变动对现金及现金等价物的影响-237,046.52-72,120.82-97,939.72-67,265.44
现金及现金等价物净增加额-185,295,980.46-104,952,250.8149,092,172.8-54,318,534.49
期末现金及现金等价物余额582,244,676.65662,588,406.3816,632,829.91767,540,657.11
最新报告期:2024-11-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西部证券李梦园1.521.822.242024-11-01
平安证券叶寅,韩盟盟1.642.062.582024-10-26
招商证券许菲菲1.541.852.212024-10-26
中信证券陈竹1.581.922.342024-09-05
华创证券郑辰1.511.832.252024-09-01
TOP↑